En esta página
01MTVA precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
MTVA MetaVia Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$1,54
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,70mínimo 52 semanas
$13,42máximo 52 semanas
Capitalización Bursátil (MRQ)
$10M
P/E
-0.2
BPA
$-7.35
tus insignias
Rango 52S
$1–$13
Calificación del Analista
BUY
Precio Objetivo
$19
P/E
-0.2
ROE
-173.5%
Margen de Beneficio Neto
-2543.7%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
MTVA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.54
Capitalización Bursátil (MRQ)
$10M
P/E
-0.2
BPA
$-7.35
ROE
-173.5%
Rango 52S
$1–$13
MTVA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 5 de diciembre de 2025 | 1-for-11 | Inversa |
| 21 de diciembre de 2023 | 1-for-8 | Inversa |
| 13 de septiembre de 2022 | 1-for-30 | Inversa |
| 31 de diciembre de 2019 | 1-for-25 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-7.352020-12-31 → 2025-12-31
Flujo de caja libre$-16M2019-12-31 → 2025-12-31
Margen neto-2543.7%2016-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | MTVA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -0.2promedio 5A ≈-3.5 | ≈-3.5 | · | · | |
| P/S | 7.0promedio 5A ≈111592.7 | ≈111592.7 | · | · | |
| P/C (MRQ) | 1.5promedio 5A ≈108.4 | ≈108.4 | 1.5 | Valor razonable | |
| Price / FCF (Precio / FCF) | -0.2promedio 5A ≈-129.8 | ≈-129.8 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -0.2promedio 5A ≈-104.0 | ≈-104.0 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.7promedio 5A ≈108.4 | ≈108.4 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | MTVA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Operating Margin (Margen Operativo) | -2687.8%promedio 5A ≈-29634.2% | ≈-29634.2% | · | · | |
| EBITDA Margin (Margen EBITDA) | -2687.8%promedio 5A ≈-29634.2% | ≈-29634.2% | · | · | |
| Pretax Margin (Margen antes de impuestos) | -2543.7%promedio 5A ≈-29354.8% | ≈-29354.8% | · | · | |
| Net Profit Margin (Margen de Beneficio Neto) | -2543.7%promedio 5A ≈-29354.8% | ≈-29354.8% | · | · | |
| ROA | -94.8%promedio 5A ≈-89.2% | ≈-89.2% | -94.1% | En línea | |
| ROE | -173.5%promedio 5A ≈-150.3% | ≈-150.3% | -176.6% | En línea | |
| ROIC | -257.0%promedio 5A ≈-182.1% | ≈-182.1% | · | · |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | MTVA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 2.1promedio 5A ≈3.6 | ≈3.6 | 2.0 | En línea | |
| Quick Ratio (Ratio Rápido) | 1.8promedio 5A ≈3.6 | ≈3.6 | 1.8 | En línea |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | MTVA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -44.6%promedio 5A ≈-3.0% | ≈-3.0% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 303.5% | · | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 67.2% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | MTVA | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | 0.0 | De primer nivel |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
25.6%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 18, 2026 | $-0.90 | $-0.84 | -7.6% |
| 31 de marzo de 2026 | May 14, 2026 | $-0.79 | $-0.76 | -4.2% |
| 31 de diciembre de 2025 | $-0.42 | $-1.27 | 66.9% | |
| 30 de septiembre de 2025 | $-1.54 | $-2.49 | 38.2% | |
| 30 de junio de 2025 | $-2.86 | $-3.48 | 17.8% | |
| 31 de marzo de 2025 | $-3.96 | $-6.76 | 41.4% | |
| 31 de diciembre de 2024 | $-5.54 | $-7.60 | 27.1% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $7M | $22M | · | · | · | · | · | · | · | · | · | |
| SG&A Expense | $7M | $7M | $7M | $9M | $9M | $8M | $3M | $2M | $10M | $6M | $3M | |
| Operating Expenses | $14M | $29M | $16M | $20M | $15M | $30M | $20M | $15M | $33M | $15M | $8M | |
| Operating Income | $-14M | $-29M | $-16M | $-20M | $-15M | $-30M | $-20M | $-15M | $-33M | $-15M | $-8M | |
| Other Non-op | $735.0K | $1M | $3M | $6M | $14.0K | $-1.0K | · | $-3.0K | $-5.0K | $-4.0K | $7.0K | |
| Pretax Income | $-13M | $-28M | $-12M | $-14M | $-15M | $-30M | $-21M | $-16M | $-33M | $-15M | $-9M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-13M | $-28M | $-12M | $-14M | $-15M | $-30M | $-21M | $-16M | $-33M | $-15M | $-9M | |
| EPS (Basic) | $-7.35 | $-39.13 | $-2.46 | $-43.42 | $-19.81 | $-1.83 | · | · | · | · | · | |
| EPS (Diluted) | $-7.35 | $-39.13 | $-2.46 | $-43.42 | $-19.81 | $-1.83 | · | · | · | · | · | |
| Shares (Basic) | 1,766,026 | 705,193 | 5,071,101 | 321,703 | 771,422 | 16,217,339 | · | · | · | · | · | |
| Shares (Diluted) | 1,766,026 | 705,193 | 5,071,101 | 321,703 | 771,422 | 16,217,339 | · | · | · | · | · | |
| EBITDA | $-14M | $-29M | $-16M | $-20M | $-15M | · | $-20M | $-23M | · | $-15M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $16M | $22M | $33M | $16M | $10M | $14M | $3M | $18M | $24M | $4M | |
| Prepaid Expense | $597.0K | $55.0K | $77.0K | $168.0K | $197.0K | $546.0K | $153.0K | $929.0K | $490.0K | $713.0K | $23.0K | |
| Other Current Assets | · | · | $64.0K | $168.0K | · | $48.0K | $42.0K | $34.0K | $25.0K | · | · | |
| Current Assets | $11M | $16M | $23M | $34M | $17M | $11M | $14M | $4M | $19M | $25M | $4M | |
| PP&E (Net) | $17.0K | $34.0K | $46.0K | $2.0K | $110.0K | $155.0K | $200.0K | $3.0K | · | · | · | |
| PP&E (Gross) | $90.0K | $88.0K | $80.0K | $30.0K | $221.0K | $218.0K | $217.0K | $3.0K | · | · | · | |
| Accum. Depreciation | $73.0K | $54.0K | $34.0K | $28.0K | $111.0K | $63.0K | $17.0K | · | · | · | · | |
| Other Non-current Assets | $21.0K | $21.0K | $21.0K | · | · | $155.0K | $34.0K | · | · | $8.0K | · | |
| Total Assets | $11M | $16M | $23M | $34M | $17M | $11M | $14M | $4M | $19M | $25M | $4M | |
| Accounts Payable | $1M | $4M | $821.0K | $708.0K | $830.0K | $3M | $638.0K | $170.0K | $4M | $2M | $531.0K | |
| Accrued Liabilities | · | · | $4M | $280.0K | $1M | $1M | $1M | $49.0K | $1M | $2M | $2M | |
| Current Liabilities | $6M | $8M | $6M | $12M | $2M | $4M | $2M | $219.0K | $6M | $4M | $9M | |
| Capital Leases | $142.0K | $58.0K | $136.0K | · | $45.0K | $70.0K | $94.0K | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $1.0K | $3.0K | $1.0K | · | |
| Total Liabilities | $6M | $8M | $6M | $12M | $2M | $4M | $2M | $360.0K | $15M | $4M | $9M | |
| Common Stock | $2.0K | $1.0K | $5.0K | $25.0K | $1.0K | $20.0K | $16.0K | $22.0K | $18.0K | $17.0K | $12.0K | |
| Paid-in Capital | $154M | $144M | $125M | $118M | $96M | $74M | $49M | $2M | $64M | $48M | · | |
| Retained Earnings | $-149M | $-136M | $-108M | $-96M | $-82M | $-67M | $-37M | $-16M | $-60M | $-27M | $-12M | |
| AOCI | · | · | · | · | $4.0K | $14.0K | $12.0K | $2.0K | · | · | · | |
| Stockholders' Equity | $5M | $8M | $17M | $22M | $15M | $7M | $12M | $-13M | $25.0K | $21M | $-12M | |
| Liabilities + Equity | $11M | $16M | $23M | $34M | $17M | $11M | $14M | $4M | $19M | $25M | $4M | |
| Shares Outstanding | 2,308,294 | 785,194 | 4,906,000 | 3,179,502 | 888,693 | 19,671,182 | 15,592,718 | 5,166,812 | 10,633,042 | 9,270,255 | 3,758,488 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $411.0K | $538.0K | $222.0K | $854.0K | $662.0K | $699.0K | $118.0K | $4M | $5M | $2M | $284.0K | |
| Deferred Tax | $-2M | $-8M | $-3M | $26M | $-4M | $-13M | $-7M | $-4M | · | · | · | |
| Operating Cash Flow | $-16M | $-25M | $-11M | $-12M | $-15M | $-11M | $-7M | $-14M | $-27M | $-11M | $-5M | |
| CapEx | $2.0K | $8.0K | $50.0K | · | $3.0K | $4.0K | $214.0K | $3.0K | · | · | · | |
| Investing Cash Flow | $-2.0K | $-8.0K | $-50.0K | $8.0K | $-586.0K | $69.0K | $-6M | $-3.0K | · | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | $10M | $3M | $6M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $3.0K | |
| Financing Cash Flow | $10M | $18M | $-80.0K | $29M | $22M | $7M | $24M | $17M | $21M | $31M | $9M | |
| Net Change in Cash | · | · | · | · | · | · | · | $481.0K | $-6M | $20M | $3M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-16M | $-25M | $-11M | · | $-15M | · | $-7M | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2687.8% | -3131.4% | -3446.0% | · | -109271.4% | · | 91709.1% | 3487.0% | · | -12891.2% | · | |
| Net Margin | -2543.7% | -2999.1% | -2705.0% | · | -109171.4% | · | 96872.7% | 3614.2% | · | -12794.7% | · | |
| Pretax Margin | -2543.7% | -2999.1% | -2705.0% | · | -109171.4% | · | 96872.7% | 3614.2% | · | -12794.7% | · | |
| EBITDA Margin | -2687.8% | -3131.4% | -3446.0% | · | -109271.4% | · | 91709.1% | 3487.0% | · | -12891.2% | · | |
| ROA | -94.8% | -141.3% | -44.3% | -55.5% | -110.1% | · | -233.1% | -122.1% | · | -99.8% | · | |
| ROE | -173.5% | -264.2% | -65.2% | -100.9% | -147.5% | · | 485.0% | -253.8% | · | -61.3% | · | |
| ROIC | -257.0% | -363.2% | -95.2% | -90.2% | -104.8% | · | -164.1% | -293.4% | · | -71.2% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.9 | 3.8 | 2.8 | 7.7 | · | 6.8 | 1.7 | · | 6.0 | · | |
| Quick Ratio | 1.8 | 1.9 | 3.8 | 2.8 | 7.6 | · | 6.7 | 1.6 | · | 5.8 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.0 | · | -0.0 | -0.0 | · | 0.0 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.31 | $0.92 | $3.40 | $24.47 | $0.55 | · | $0.79 | $0.55 | · | $2.23 | · | |
| Revenue / Share | $0.29 | $0.12 | $0.09 | · | $0.00 | · | · | · | · | · | · | |
| Cash Flow / Share | $-8.89 | $-3.19 | $-2.13 | $-4.55 | $-0.65 | · | · | · | · | · | · | |
| Cash / Share | $4.45 | $1.85 | $4.57 | $37.54 | $0.61 | · | $0.89 | $1.33 | · | $2.59 | · | |
| EPS (TTM) | $-7.35 | $-39.13 | $-2.46 | $-43.42 | $-19.81 | $-1.83 | · | · | · | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -44.6% | 99.6% | · | · | -64.1% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | 303.5% | 127.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 67.2% | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $510.0K | $920.0K | $461.0K | $20.0K | $14.0K | $39.0K | $-22.0K | $-40.0K | $-286.0K | $114.0K | · | |
| Net Income TTM | $-13M | $-28M | $-12M | $-14M | $-15M | $-30M | $-21M | $-16M | $-33M | $-15M | · | |
| Market Cap | $19M | $18M | $18M | $5M | $7.81B | · | $32.74B | $69.33B | · | $436.07B | · | |
| P/E | -1.1 | -0.1 | -1.5 | -0.1 | -14.8 | -688.5 | · | · | · | · | · | |
| P/S | 38.1 | 19.1 | 39.3 | 255.2 | 557611.9 | · | -1488395.8 | -1733247.4 | · | 3825200.0 | · | |
| P/B | 3.6 | 2.2 | 1.1 | 0.2 | 534.8 | · | 2663.9 | 8918.2 | · | 21135.8 | · | |
| P / Tangible Book | 3.6 | 2.2 | 1.1 | 0.2 | 534.8 | 3441.0 | · | · | · | · | · | |
| P / Cash Flow | -1.2 | -0.7 | -1.7 | -0.4 | -515.8 | · | -4651.9 | -3164.2 | · | -39488.6 | · | |
| P / FCF | -1.2 | -0.7 | -1.7 | · | -515.7 | · | -4514.6 | · | · | · | · | |
| Earnings Yield | -87.3% | -1927.6% | -66.5% | -755.9% | -6.8% | -0.15% | · | · | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $2M | $241.0K | $2M | $2M | $2M | $4M | $5M | $8M | · | · | · | · | · | · | · | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $3M | |
| Operating Expenses | $5M | $4M | $2M | $3M | $4M | $4M | $6M | $6M | $10M | $7M | $6M | $4M | $4M | $3M | $10M | $3M | |
| Operating Income | $-5M | $-4M | $-2M | $-3M | $-4M | $-4M | $-6M | $-6M | $-10M | $-7M | $-6M | $-4M | $-4M | $-3M | $-10M | $-3M | |
| Other Non-op | $69.0K | $202.0K | $116.0K | $98.0K | $306.0K | $215.0K | $412.0K | $607.0K | $31.0K | $167.0K | $353.0K | $75.0K | $3M | $-84.0K | · | · | |
| Pretax Income | $-5M | $-4M | $-2M | $-3M | $-4M | $-4M | $-5M | $-6M | $-10M | $-7M | $-5M | $-4M | $-734.0K | $-3M | $-5M | $-3M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-5M | $-4M | $-2M | $-3M | $-4M | $-4M | $-5M | $-6M | $-10M | $-7M | $-5M | $-4M | $-734.0K | $-3M | $-5M | $-3M | |
| EPS (Basic) | $-0.90 | $-0.79 | $-6.59 | $-0.14 | $-2.87 | $-3.93 | $-35.41 | $-0.55 | $-1.85 | $-1.32 | $-1.05 | $-0.75 | $-0.15 | $-0.51 | $-32.96 | $-3.50 | |
| EPS (Diluted) | $-0.90 | $-0.79 | $-6.59 | $-0.14 | $-2.87 | $-3.93 | $-35.41 | $-0.55 | $-1.85 | $-1.32 | $-1.05 | $-0.75 | $-0.15 | $-0.51 | $-32.96 | $-3.50 | |
| Shares (Basic) | 5,931,875 | 4,859,567 | · | 24,415,876 | 1,389,753 | 933,109 | · | 10,214,087 | 5,428,906 | 5,089,408 | · | 5,075,817 | 5,059,003 | 5,059,003 | · | 888,693 | |
| Shares (Diluted) | 5,931,875 | 4,859,567 | · | 24,415,876 | 1,389,753 | 933,109 | · | 10,214,087 | 5,428,906 | 5,089,408 | · | 5,075,817 | 5,059,003 | 5,059,003 | · | 888,693 | |
| EBITDA | $-5M | $-4M | · | $-3M | $-4M | $-4M | · | $-6M | $-10M | $-7M | · | $-4M | $-4M | $-3M | · | $-3M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $14M | $10M | $14M | $18M | $11M | $16M | $22M | $28M | $16M | $22M | $26M | $29M | $31M | $33M | $6M | |
| Prepaid Expense | $433.0K | $431.0K | $597.0K | $369.0K | $726.0K | $771.0K | $55.0K | $266.0K | $583.0K | $776.0K | $77.0K | $308.0K | $486.0K | $670.0K | $168.0K | $859.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | $508.0K | · | · | · | · | $168.0K | · | |
| Current Assets | $13M | $14M | $11M | $15M | $18M | $12M | $16M | $22M | $29M | $17M | $23M | $26M | $29M | $31M | $34M | $8M | |
| PP&E (Net) | $8.0K | $12.0K | $17.0K | $22.0K | $27.0K | $30.0K | $34.0K | $39.0K | $44.0K | $47.0K | $46.0K | $41.0K | $5.0K | $5.0K | $2.0K | $3.0K | |
| PP&E (Gross) | $90.0K | $90.0K | $90.0K | $90.0K | $90.0K | $88.0K | $88.0K | $88.0K | $88.0K | $85.0K | $80.0K | · | · | · | $30.0K | $30.0K | |
| Accum. Depreciation | $82.0K | $78.0K | $73.0K | $68.0K | $63.0K | $58.0K | $54.0K | $49.0K | $44.0K | $38.0K | $34.0K | $30.0K | $29.0K | $29.0K | $28.0K | $27.0K | |
| Other Non-current Assets | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | · | · | · | · | |
| Total Assets | $13M | $14M | $11M | $15M | $18M | $12M | $16M | $22M | $29M | $17M | $23M | $26M | $29M | $31M | $34M | $8M | |
| Accounts Payable | $921.0K | $1M | $1M | $3M | $3M | $3M | $4M | $1M | $3M | $2M | $821.0K | $2M | $967.0K | $1M | $708.0K | $1M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $4M | · | $2M | $2M | $417.0K | $280.0K | $544.0K | |
| Current Liabilities | $6M | $5M | $6M | $8M | $9M | $8M | $8M | $9M | $10M | $7M | $6M | $5M | $4M | $11M | $12M | $2M | |
| Capital Leases | $103.0K | $123.0K | $142.0K | · | $15.0K | $37.0K | $58.0K | $79.0K | $98.0K | $117.0K | $136.0K | $153.0K | · | · | · | · | |
| Total Liabilities | $6M | $5M | $6M | $8M | $9M | $8M | $8M | $9M | $10M | $7M | $6M | $5M | $4M | $11M | $12M | $2M | |
| Common Stock | $7.0K | $5.0K | $2.0K | $24.0K | $24.0K | $9.0K | $1.0K | $9.0K | $8.0K | $5.0K | $5.0K | $38.0K | $38.0K | $27.0K | $25.0K | $1.0K | |
| Paid-in Capital | $165M | $162M | $154M | $153M | $153M | $144M | $144M | $144M | $144M | $125M | $125M | $124M | $124M | $119M | $118M | $97M | |
| Retained Earnings | $-158M | $-153M | $-149M | $-147M | $-144M | $-140M | $-136M | $-131M | $-125M | $-115M | $-108M | $-103M | $-99M | $-98M | $-96M | $-91M | |
| Stockholders' Equity | $7M | $9M | $5M | $6M | $10M | $4M | $8M | $13M | $19M | $10M | $17M | $22M | $25M | $21M | $22M | $6M | |
| Liabilities + Equity | $13M | $14M | $11M | $15M | $18M | $12M | $16M | $22M | $29M | $17M | $23M | $26M | $29M | $31M | $34M | $8M | |
| Shares Outstanding | 6,575,656 | 5,164,370 | 2,308,294 | 24,215,000 | 24,194,000 | 8,655,000 | 785,194 | 8,609,000 | 8,221,000 | 4,906,000 | 4,906,000 | 38,429,185 | 38,241,685 | 27,176,685 | 3,179,502 | 888,693 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $130.0K | $100.0K | $71.0K | $97.0K | $111.0K | $132.0K | $160.0K | $139.0K | $134.0K | $105.0K | $100.0K | $172.0K | $24.0K | $-74.0K | $218.0K | $218.0K | |
| Operating Cash Flow | $-4M | $-4M | $-5M | $-3M | $-3M | $-5M | $-5M | $-6M | $-7M | $-6M | $-3M | $-3M | $-2M | $-3M | $-2M | $-2M | |
| CapEx | · | · | $0 | $0 | · | · | $0 | $0 | $3.0K | $5.0K | $9.0K | $37.0K | $0 | $4.0K | · | · | |
| Investing Cash Flow | · | · | $0 | $0 | · | · | $0 | $0 | $-3.0K | $-5.0K | $-9.0K | $-37.0K | $0 | $-4.0K | $0 | $0 | |
| Financing Cash Flow | $3M | $8M | $861.0K | $-357.0K | $9M | $-12.0K | $-183.0K | $-717.0K | · | · | $0 | $0 | · | · | $29M | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-6M | · | · | · | $-3M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -7376.7% | -4735.3% | · | -2301.3% | -2945.9% | -3035.9% | · | -2019.0% | -6148.8% | -2903.4% | · | -2403.1% | · | · | · | · | |
| Net Margin | -7282.2% | -4497.7% | · | -2236.4% | -2736.3% | -2868.0% | · | -1823.2% | -6129.9% | -2832.9% | · | -2356.8% | · | · | · | · | |
| Pretax Margin | -7282.2% | -4497.7% | · | -2236.4% | -2736.3% | -2868.0% | · | -1823.2% | -6129.9% | -2832.9% | · | -2356.8% | · | · | · | · | |
| EBITDA Margin | -7376.7% | -4735.3% | · | -2301.3% | -2945.9% | -3035.9% | · | -2019.0% | -6148.8% | -2903.4% | · | -2403.1% | · | · | · | · | |
| ROA | -33.5% | -28.8% | · | -18.3% | -16.9% | -25.2% | · | -23.3% | -34.7% | -27.7% | · | -22.5% | -3.7% | -11.6% | · | -39.8% | |
| ROE | -64.6% | -56.8% | · | -35.0% | -28.0% | -50.8% | · | -32.8% | -45.6% | -43.9% | · | -27.8% | -4.3% | -16.1% | · | -51.6% | |
| ROIC | -78.9% | -44.4% | · | -54.9% | -44.7% | -88.7% | · | -48.3% | -53.2% | -68.3% | · | -18.1% | -15.1% | -12.3% | · | -52.3% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.7 | · | 1.7 | 2.1 | 1.6 | · | 2.4 | 2.9 | 2.5 | · | 5.5 | 7.3 | 2.9 | · | 4.7 | |
| Quick Ratio | 2.0 | 2.6 | · | 1.7 | 2.0 | 1.5 | · | 2.4 | 2.9 | 2.3 | · | 5.5 | 7.2 | 2.8 | · | 3.9 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.04 | $1.76 | · | $0.26 | $0.40 | $0.51 | · | $1.50 | $2.30 | $2.05 | · | $0.56 | $0.66 | $0.75 | · | $6.68 | |
| Revenue / Share | $0.01 | $0.02 | · | $0.01 | $0.01 | $0.01 | · | $0.03 | $0.03 | $0.05 | · | $0.00 | · | · | · | · | |
| Cash Flow / Share | · | $-0.88 | · | · | · | $-0.47 | · | · | · | $-1.27 | · | · | · | $-0.06 | · | · | |
| Cash / Share | $1.92 | $2.66 | · | $0.59 | $0.73 | $1.29 | · | $2.52 | $3.40 | $3.26 | · | $0.67 | $0.75 | $1.13 | · | $7.15 | |
| EPS (TTM) | $-8.42 | $-10.39 | · | $-42.35 | $-42.76 | $-41.74 | · | $-4.77 | $-4.97 | $-3.27 | · | $-34.37 | $-37.12 | $-40.69 | · | $-25.28 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $394.0K | $467.0K | · | $634.0K | $793.0K | $811.0K | · | $1M | $862.0K | · | · | · | $14.0K | $14.0K | · | $14.0K | |
| Net Income TTM | $-14M | $-13M | · | $-16M | $-18M | $-25M | · | $-28M | $-26M | $-17M | · | $-12M | $-11M | $-14M | · | $-14M | |
| Market Cap | $9M | $6M | · | $23M | $16M | $13M | · | $27M | $40M | $20M | · | $146M | $134M | $154M | · | $97M | |
| P/E | -0.2 | -0.1 | · | -0.0 | -0.0 | -0.0 | · | -0.7 | -1.0 | -1.3 | · | -0.1 | -0.1 | -0.1 | · | -4.3 | |
| P/S | 23.9 | 13.3 | · | 35.9 | 19.6 | 16.4 | · | 27.0 | 46.2 | · | · | · | 9549.5 | 11026.0 | · | 6952.1 | |
| P/B | 1.4 | 0.7 | · | 3.6 | 1.6 | 3.0 | · | 2.1 | 2.1 | 2.0 | · | 6.8 | 5.3 | 7.5 | · | 16.4 | |
| P / Tangible Book | 1.4 | 0.7 | · | 3.6 | 1.6 | 3.0 | · | 2.1 | 2.1 | 2.0 | · | 6.8 | 5.3 | 7.5 | · | 16.4 | |
| P / Cash Flow | · | -1.5 | · | · | · | -2.8 | · | · | · | -3.1 | · | · | · | -60.6 | · | · | |
| Earnings Yield | -588.8% | -865.8% | · | -4505.3% | -6650.1% | -2710.4% | · | -150.5% | -102.7% | -80.0% | · | -902.6% | -1061.8% | -716.4% | · | -23.1% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Margen Operativo % | -2687.8% | -3131.4% | -3446.0% | · | -109271.4% |
| Beneficio neto | $-13M | $-28M | $-12M | $-14M | $-15M |
| EPS Diluido | $-7.35 | $-39.13 | $-2.46 | $-43.42 | $-19.81 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 1.9 | 1.9 | 3.8 | 2.8 | 7.7 |
| Ratio Rápido | 1.8 | 1.9 | 3.8 | 2.8 | 7.6 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-16M | $-25M | $-11M | · | $-15M |
Propietarios institucionales (13F) 18 declarantes · $540K total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
18
Valor en tenencia
$540K
Nuevas posiciones
5
Posiciones cerradas
0
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 5 (-1 vs trimestre anterior) | 0 (-4 vs trimestre anterior) | 4 (+2 vs trimestre anterior) | 3 (+2 vs trimestre anterior) | +222K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| JANE STREET GROUP, LLC | $176 723 | 123 583 | 32,72% | Acciones |
| VANGUARD GROUP INC | $169 141 | 20 088 | 31,31% | Acciones |
| CITADEL ADVISORS LLC | $87 525 | 61 206 | 16,20% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $30 478 | 21 314 | 5,64% | Acciones |
| UBS Group AG | $18 515 | 12 948 | 3,43% | Acciones |
| Scientech Research LLC | $17 180 | 12 014 | 3,18% | Acciones |
| Aries Wealth Management | $14 300 | 10 000 | 2,65% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $12 754 | 8 919 | 2,36% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $9 924 | 6 940 | 1,84% | Acciones |
| Tower Research Capital LLC (TRC) | $3 179 | 2 223 | 0,59% | Acciones |
| SBI Securities Co., Ltd. | $386 | 270 | 0,07% | Acciones |
| Virtu Financial LLC | $43 | 29 933 | 0,01% | Acciones |
| MORGAN STANLEY | $14 | 10 | 0,00% | Acciones |
| BlackRock, Inc. | $10 | 7 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $4 | 3 | 0,00% | Acciones |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $3 | 2 | 0,00% | Acciones |
| BROWN BROTHERS HARRIMAN & CO | $3 | 2 | 0,00% | Acciones |
| DANSKE BANK A/S | $3 | 2 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 7 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Dong-A ST Co., Ltd., Dong-A Socio Holdings Co., Ltd. | 20 de mayo de 2025 | 51,10% | Enmienda | · | SEC |
| (S.S. or ×8 presentaciones | 20 de septiembre de 2024 | · | Presentación inicial | · | SEC |
| JK BioPharma Solutions, Inc., Sun Dae Kang ×3 presentaciones | 23 de septiembre de 2022 | · | Presentación inicial | · | SEC |
| The E&Healthcare Investment Fund II, The E&Healthcare Investment Fund No. 6, The E&Healthcare Investment Fund No. 7, E&Investment, Inc., Na Yeon Kim ×4 presentaciones | 5 de agosto de 2022 | · | Presentación inicial | Inversión pasiva | SEC |
| NeuroBo Therapeutics, Inc. (f/k/a/ NeuroBo Pharmaceuticals, Inc.) | 16 de enero de 2020 | · | Presentación inicial | · | SEC |
| Charles L. Bisgaier ×2 presentaciones | 10 de enero de 2020 | · | Presentación inicial | M&A / venta | SEC |
| NeuroBo Pharmaceuticals, Inc. | 2 de agosto de 2019 | · | Presentación inicial | M&A / venta | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 29 insiders · 12 directivos · 20 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Hyung Heon Kim | CEO & President | 23 de enero de 2026 A | 37 545 | 0 | 0 | $0 |
| Ben Gil Price | CEO and President | 3 de noviembre de 2021 A | · | 0 | 0 | $0 |
| Sooch Mina | President & CEO | 25 de noviembre de 2016 A | 693 732 | 0 | 0 | $0 |
| Marshall H Woodworth | Chief Financial Officer | 23 de enero de 2026 A | 30 734 | 0 | 0 | $0 |
| Jeffrey S Mathiesen | Chief Financial Officer | 28 de enero de 2018 A | 14 134 | 0 | 0 | $0 |
| Akash Bakshi | SVP and COO | 31 de diciembre de 2020 A | 884 072 | 0 | 0 | $0 |
| Mark Versavel | Chief Medical Officer | 30 de diciembre de 2019 A | · | 0 | 0 | $0 |
| Seth Reno | Chief Commercial Officer | 24 de julio de 2019 A | 118 286 | 0 | 0 | $0 |
| Charles Bisgaier PhD | Chief Scientific Off. & Chair | 24 de julio de 2019 A | 1 348 914 | 0 | 0 | $0 |
| Lee Scott Golden | Chief Medical Officer | 28 de enero de 2018 A | · | 0 | 0 | $0 |
| David Lowenschuss | Chief Legal Off. & Secretary | 10 de agosto de 2016 P | 806 247 | 0 | 0 | $0 |
| Carmen Daniela Oniciu | Vice President | 10 de agosto de 2016 C | 152 401 | 0 | 0 | $0 |
| Michael Salsbury | Consejero | 8 de junio de 2026 A | 21 338 | 0 | 0 | $0 |
| James Patrick Tursi | Consejero | 8 de junio de 2026 A | 20 568 | 0 | 0 | $0 |
| Jason L Groves | Consejero | 8 de junio de 2026 A | 21 338 | 0 | 0 | $0 |
| Mark A Glickman | Consejero | 8 de junio de 2026 A | 20 629 | 0 | 0 | $0 |
| Andrew I Koven | Consejero | 8 de junio de 2026 A | 21 339 | 0 | 0 | $0 |
| Gordon D Strickland | Consejero | 8 de junio de 2026 A | 21 339 | 0 | 0 | $0 |
| Kim Na Yeon | Consejero | 27 de julio de 2023 A | 101 459 | 0 | 0 | $0 |
| Richard Kang | Consejero | 9 de junio de 2022 A | · | 0 | 0 | $0 |
| Douglas J Swirsky | Consejero | 1 de septiembre de 2020 A | · | 0 | 0 | $0 |
| Jeong Gyun Oh | Consejero | 13 de enero de 2020 A | 240 051 | 0 | 0 | $0 |
| Steven R. Gullans Ph.D. | Consejero | 13 de enero de 2020 A | 300 000 | 0 | 0 | $0 |
| Tae Heum Jeong | Consejero | 13 de enero de 2020 A | · | 0 | 0 | $0 |
| Andy Sassine | Consejero | 24 de julio de 2019 A | 151 264 | 0 | 0 | $0 |
| Pedro Lichtinger | Consejero | 24 de julio de 2019 A | 74 833 | 0 | 0 | $0 |
| Kenneth W Kousky | Consejero | 24 de julio de 2019 A | 26 935 | 0 | 0 | $0 |
| Kent P. Hawryluk | Consejero | 29 de enero de 2018 A | 81 889 | 0 | 0 | $0 |
| DONG-A ST CO., LTD | Propietario del 10% | 8 de mayo de 2025 P | 9 995 679 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 1 ETF
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 8 919 SH | 19 de agosto de 2026 | Diario |
MTVA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 8 analistas
COMPRA
Objetivo mediano
$20.00
+1198,7%
2 25,0%
Compra fuerte
5 62,5%
Compra
1 12,5%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
3 analistas · 2026-10-03Objetivo medio $19.33 +1155,4%
← Por Debajo de Todos los Objetivos
Precio Actual $1.54
Mín$8.00
Media$19.33
Máx$30.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| MTVA | $19M | -1.1 | -44.6% | -2543.7% | -173.5% | · |
| INTS | $1M | -0.0 | · | · | -165.1% | · |
| GTBP | $20M | -0.1 | · | · | -645.4% | · |
| LTRN | · | -1.9 | · | · | · | · |
| SNTI | · | -0.4 | -40.2% | · | · | · |
| XCUR | $35M | -6.9 | · | · | -77.3% | · |
| MBRX | · | · | · | · | · | · |
| APRE | $7M | -0.4 | · | · | -97.5% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026